National Institutes of Health
The National Institutes of Health (NIH) is the government-sponsored agency for health research and development of medical technology. Founded by the U.S. Department of Health and Human Services, the NIH consists of 27 institutes, including the National Cancer Institute, which conducts most of the National Institute of Health's mesothelioma research.
The NIH is the world's largest source of funding for medical research, and over 80 percent of their budget is distributed to university research labs. The NIH also maintains its own laboratories, including the NIH Clinical Center in Bethesda, Maryland, which is the largest clinical research hospital in the world.
Clinical Trials at the National Institutes of Health Clinical Center
The main focus of the NIH Clinical Center is the clinical trials program at the Center for Cancer Research (CCR). At any given time, the National Institutes of Health's CRR operates more than 150 cancer-focused clinical trials. Currently, eight mesothelioma clinical trials are in process at the facility. Clinical trials are provided as a way for researchers to better understand the way that mesothelioma responds to treatment while patients can access emerging therapies that may provide better results than standard options.
These clinical trials provide treatment at no cost, and in many cases, the NIH can cover transportation costs after a patient has been accepted into the program. Although the trials are conducted in Maryland, cancer patients from anywhere in the world may be accepted if they qualify. Mesothelioma patients may also be eligible for financial aid to cover any medical expenses from other treatment. To learn more about these options, request a free informational packet from the Mesothelioma Center.
Recent Mesothelioma Studies Conducted by the National Institutes of Health
In the 2010 fiscal year, the NIH granted more than $7,914,000 to 16 mesothelioma research projects. Five of these projects were conducted at the National Cancer Institute, while the others, led by top mesothelioma researchers like Harvey Pass, Raphael Bueno and Michele Carbone, were performed at NCI-designated research laboratories. Some of the topics studied included:
- Immunotherapy for malignant mesothelioma
- Mesothelin as a mesothelioma biomarker
- Targeted radiotherapy for mesothelioma
- Mesothelioma pathogenesis
- Prognostic and diagnostic mesothelioma tests
Studies from the 2009 fiscal year, which received $11,637,205 in NIH funding, included the pathogenesis of mesothelioma, clinical trials with immunotoxins and computerized analysis of mesothelioma CT scans.
For help finding mesothelioma specialists at NIH-designated cancer centers, or other care facilities in your area, use the Doctor Match Program sponsored by the Mesothelioma Center.
NCI-Designated Comprehensive Cancer Centers:
- Abramson Cancer Center
University of Pennsylvania; Philadelphia, PA - Arizona Cancer Center
University of Arizona; Tuscon, AZ - The Cancer Institute of New Jersey
Robert Wood Johnson Medical School; New Brunswick, NJ - Case Comprehensive Cancer Center
Case Western Reserve University; Cleveland, OH - Chao Family Comprehensive Cancer Center
University of California at Irvine; Orange, CA - City of Hope Comprehensive Cancer Center
Duarte, CA - Dana-Farber/Brigham and Women's Cancer Center
Harvard Medical School; Boston, MA - Duke Cancer Institute
Duke University Medical Center; Durham, NC - Fox Chase Cancer Center
Philadelphia, PA - Fred Hutchinson/University of Washington Cancer Consortium
Fred Hutchinson Cancer Research Center; Seattle, WA - Georgetown Lombardi Comprehensive Cancer Center
Washington, DC - Holden Comprehensive Cancer Center
The University of Iowa; Iowa City, IA - Herbert Irving Comprehensive Cancer Center
College of Physicians & Surgeons, Columbia University; New York, NY - Jonsson Comprehensive Cancer Center
University of California at Los Angeles - The Barbara Ann Karmanos Cancer Institute
Wayne State University School of Medicine; Detroit, MI - Robert H. Lurie Comprehensive Cancer Center
Northwestern University; Chicago, IL - MD Anderson Cancer Center
University of Texas; Houston, TX - Masonic Cancer Center
at the University of Minnesota; Minneapolis, MN - Mayo Clinic Cancer Center
Mayo Clinic Rochester; Rochester, MN - Memorial Sloan-Kettering Cancer Center
New York, NY - H. Lee Moffitt Cancer Center
at the University of South Florida; Tampa, FL - Moores Cancer Center
University of California, San Diego; La Jolla, CA - Norris Cotton Cancer Center
Dartmouth-Hitchcock Medical Center; Lebanon, NH - Arthur G. James Cancer Hospital and Solove Research Institute
The Ohio State University Comprehensive Cancer Center; Columbus, OH - Roswell Park Cancer Institute
Buffalo, NY - St. Jude Children's Research Hospital
Memphis, TN - Sidney Kimmel Comprehensive Cancer Center
at Johns Hopkins University; Baltimore, MD - Alvin J. Siteman Cancer Center
Washington University School of Medicine; St. Louis, MO - University of Alabama Comprehensive Cancer Center
Birmingham, AL - UCSF Helen Diller Family Comprehensive Cancer Center
University of California San Francisco - UNC Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hill - University of Chicago Comprehensive Cancer Center
Chicago, IL - University of Colorado Cancer Center
University of Colorado at Denver & Health Sciences Center; Aurora, CO - University of Michigan Comprehensive Cancer Center
Ann Arbor, MI - University of Pittsburgh Cancer Centers
University of Pittsburgh Cancer Institute; Pittsburgh, PA - USC/Norris Comprehensive Cancer Center
University of Southern California; Los Angeles, CA - UW Paul P. Carbone Comprehensive Cancer Center
University of Wisconsin; Madison, WI - Vanderbilt-Ingram Cancer Center
Vanderbilt University; Nashville, TN - Wake Forest Comprehensive Cancer Center
Wake Forest University; Winston-Salem, NC - Yale Cancer Center
Yale University School of Medicine; New Haven, CT
-
05/18/2012 -
The Queen of Disco Donna Summer died on Thursday in her Naples, Florida, home after a quiet battle with lung cancer.
She was 63.
The five-time G ..
-
05/17/2012 -
Thoracic surgeon Robert Cameron, M.D., used his second annual Symposium for Lung-Sparing Therapies for Malignant Pleural Mesothelioma last week in Los ..
-
05/17/2012 -
Researchers in Singapore have uncovered new technology for studying cancer stem cells that could spark quicker development of a more effective therapy ..






